MedMen To Appoint New Independent Board At Gotham Green’s Discretion

Following Medmen Enterprises’ (CSE: MMEN) horrendous financials filed yesterday for fiscal 2019, the firm announced that it has amended the terms of its financing with Gotham Green Partners. The new terms will see Medmen able to access funding earlier, albeit at a decreased amount. The major catch however, is that the firm will be required to shake up its Board of Directors.

The new terms of the facility being offered by Gotham Green amounts to the same cumulative figure of US$250 million in financing. However, terms have changed so that tranche 3 consists of only US$10 million in financing, whereas it previously amounted to $75 million. The tranche will also be made available within the next 30 days, whereas it was originally scheduled for December release. The fourth tranche will now consist of a total US$115 million. However, the issuance of the fourth tranche must be agreed to by both Medmen as well as Gotham Green Partners.

Other modifications to the terms of the secured convertible debentures include:

Cambria Gold Mines — sponsored Sponsored · Cambria Gold Mines
  • a reduction in required minimum cash balances,
  • removal of restrictions on equity issuances, and
  • an additional ability to spin-out or borrow against certain non-core assets, in addition to sales and indebtedness that were permitted prior to the amendment.

As a condition for the amended facilities, it appears that Medmen’s management team and founders may lose a bit of control. Gotham Green has required that the Board of Directors of the firm be shaken up with new independent directors, that are to form a majority on the board. Medmen will propose candidates for directorship, with Gotham Green giving the final approval, in a sign of CEO and co-founder Adam Bierman’s, as well as President and co-founder Andrew Modlin’s, loosening grip on control of the firm.

Medmen Enterprises closed yesterdays session at $1.80 on the CSE.


Information for this briefing was found via Sedar and MedMen. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Gold, Silver & the $1.48 Quadrillion Derivatives Threat | Lynette Zang – Zang International

These Mining Stocks Have Huge Upside… But Here’s the Catch | Oct. 19-23 – Weekly Mining Mailbag

Selkirk Copper: Why The PEA Discount?

Recommended

Blue Jay Gold Signs Ocean Partners Deal to Ship Steller Stockpiles Through 2027

Krait Critical Minerals Signs Option for Historical Nevada King Antimony Mine

Related News

Tilray: Analysts Leave Targets Unchanged After MedMen Investment

On August 17, Tilray (NASDAQ: TLRY) made the announcement that they formed a new limited...

Thursday, August 19, 2021, 01:03:00 PM

Medmen Closes Sale Of Florida Assets To Ex-Bluma Wellness Execs

Medmen Enterprises (CSE: MMEN) has finally closed the sale of its Florida operation, albeit at...

Tuesday, August 23, 2022, 08:45:30 AM

Medmen Announces Layoffs, Divestment of Assets, Focus on SG&A Reduction

Medmen Enterprises (CSE: MMEN) will be the next cannabis firm to conduct layoffs in the...

Friday, November 15, 2019, 04:38:02 PM

Medmen Signs Term Sheets to Divest Arizona and Illinois Assets, Reduces Financing

Medmen Enterprises (CSE: MMEN) this morning announced progress in its recent decision to sell certain...

Friday, December 27, 2019, 08:58:47 AM

Cresco Labs Announces At-The-Market Offering Amid Share Unlock

Cresco Labs (CSE: CL) this morning announced an at-the-market offering, also known as an ATM,...

Tuesday, December 3, 2019, 08:57:21 AM